- ProductsInvestment SuiteExclusiveFeatures
- PlatformTrading PlatformsFeatures and ToolsCalculatorsPricing
- ResearchResearch CallsResearch Reports
- MarketStocksIndicesMutual FundsIPO
- LearnStockshaalaResourceInvesting GuideEvents
- Partner
- Support
Products
Platform
Research
Market
Learn
Compare SBI Healthcare Opportunities Fund vs ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Fund Details
Risk | Very High | Very High |
Rating | 5.0 | 4.0 |
Min SIP Amount | ₹500 | ₹100 |
Expense Ratio | 1.94 | 1.94 |
NAV | ₹422.77 | ₹37.57 |
Fund Started | 04 Jun 1999 | 25 Jun 2018 |
Fund Size | ₹3610.51 Cr | ₹4914.64 Cr |
Exit Load | Exit load of 0.50% if redeemed within 15 days | Exit load of 1% if redeemed within 15 days. |
Risk
Very High
Very High
Rating
5.0
4.0
Min SIP Amount
₹500
₹100
Expense Ratio
1.94
1.94
NAV
₹422.77
₹37.57
Fund Started
04 Jun 1999
25 Jun 2018
Fund Size
₹3610.51 Cr
₹4914.64 Cr
Exit Load
Exit load of 0.50% if redeemed within 15 days
Exit load of 1% if redeemed within 15 days.
Returns
1 Year | 24.04% | 24.40% |
3 Year | 23.61% | 23.98% |
5 Year | 25.30% | 25.65% |
1 Year
24.04%
24.40%
3 Year
23.61%
23.98%
5 Year
25.30%
25.65%
Holding Analysis
Equity | 96.93% | 98.28% |
Cash | 2.99% | 1.72% |
Equity
96.93%
98.28%
Cash
2.99%
1.72%
Top Holdings
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 13.45% |
Max Healthcare Institute Ltd. | 6.68% |
Divi's Laboratories Ltd. | 6.00% |
Cipla Ltd. | 4.79% |
Lupin Ltd. | 4.72% |
Lonza Group Ag | 4.38% |
Mankind Pharma Ltd. | 3.76% |
Krishna Institute of Medical Sciences Ltd | 3.72% |
Jupiter Life Line Hospitals Ltd. | 3.54% |
Ami Organics Ltd. | 3.38% |
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 13.50% |
Dr. Reddy's Laboratories Ltd. | 8.95% |
Cipla Ltd. | 8.85% |
Divi's Laboratories Ltd. | 6.71% |
Aurobindo Pharma Ltd. | 5.30% |
Lupin Ltd. | 4.73% |
Alkem Laboratories Ltd. | 4.42% |
Mankind Pharma Ltd. | 3.50% |
Gland Pharma Ltd. | 3.39% |
Zydus Lifesciences Ltd. | 3.10% |
Fund Manager
Name | Tanmaya Desai | Dharmesh Kakkad |
Start Date | 27 Jun 2011 | 23 Feb 2021 |
Name
Tanmaya Desai
Dharmesh Kakkad
Start Date
27 Jun 2011
23 Feb 2021
About Fund
Description | The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space. | The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies. |
Launch Date | 04 Jun 1999 | 25 Jun 2018 |
Description
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Launch Date
04 Jun 1999
25 Jun 2018